Redmile Group, LLC - 31 Mar 2025 SCHEDULE 13G/A Report for Immunome, Inc. Common Stock, $0.0001 Par Value (IMNM)

Filing Manager
Redmile Group, LLC
Reporting Manager
Redmile Group, LLC
Security
Immunome, Inc. Common Stock, $0.0001 Par Value
Symbol
IMNM
Shares outstanding
86,470,758 shares
Disclosed Ownership
5,361,187 shares
Ownership
6.2%
Form type
SCHEDULE 13G/A
Filing time
15 May 2025, 21:01:01 UTC
Date of event
31 Mar 2025
Next filing
17 Feb 2026
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Redmile Group, LLC 6.2% 5,361,187 0 5,361,187 /s/ Jeremy C. Green Managing Member
Jeremy C. Green 6.2% 5,361,187 0 5,361,187 /s/ Jeremy C. Green Jeremy C. Green
Redmile Biopharma Investments III, L.P. 4.5% 3,879,415 0 3,879,415 /s/ Jeremy C. Green Managing Member of Redmile Biopharma Investments III (GP), LLC, general partner of Redmile Biopharma Investments III, L.P.